The healthcare solutions provider Sagility India opened its initial public offering (IPO) on November 5, 2024, with a price band set between ₹28 and ₹30 per share. As the IPO enters its second day, the public offering is seeing a warm response, especially from retail investors.
By 10:00 AM on Day 2, the IPO had been subscribed 0.25 times overall, with the retail portion reaching 1.2 times subscription, indicating strong interest from individual investors. The NII (non-institutional investor) portion was subscribed 0.08 times, suggesting cautious optimism among larger investors.
IPO Details and Grey Market Premium (GMP)
Sagility India’s IPO comprises a complete offer for sale (OFS) by existing shareholders, totaling ₹2,106.60 crore. This means the proceeds will go to the selling stakeholders rather than the company’s expansion.
In the grey market, Sagility India’s shares currently trade at a ₹3 premium, hinting at modest demand. However, the premium remains low compared to other IPOs, indicating a wait-and-watch approach by grey market investors.
| Details | Sagility India IPO |
|---|---|
| Price Band | ₹28 – ₹30 |
| Grey Market Premium (GMP) | ₹3 |
| Lot Size | 500 shares |
| Subscription Period | November 5 – November 7, 2024 |
| Lead Managers | ICICI Securities, IIFL Securities |
Analyst Opinions: Should You Invest?
Analysts have shared varied opinions on Sagility India’s IPO:
- Buy Recommendation: StoxBox and Master Capital recommend subscribing to the IPO for long-term potential. With its deep client relationships in the U.S. healthcare market, Sagility India is seen as a stable investment for those looking at the sector’s growth.
- Hold/Wait Recommendation: Some analysts remain cautious due to the company’s high valuation, suggesting that investors wait until Sagility India demonstrates profitability and financial stability.
Company Overview and Market Position
Sagility India, a healthcare solutions provider, operates primarily in the U.S. market, catering to both payers and providers. The company’s growth strategy focuses on expanding tech-enabled services, with strong client retention due to its expertise in navigating complex U.S. healthcare workflows. While Sagility India remains unprofitable, it shows promise in a sector with consistent growth.
Disclaimer: This article provides a summary of Sagility India’s IPO based on available data and market opinions. Investors should conduct independent research before making investment decisions.
Click here to know more.
